From Our 2010 Archives
New Morning-After Pill Ella Wins FDA Approval
Pill Effective Up to 5 Days After Sex
Daniel J. DeNoon
Reviewed By Louise Chang, MD
Aug. 13, 2010 -- The FDA has approved Ella, a new morning-after contraceptive pill effective for up to five days after unprotected sex or contraceptive failure.
An FDA expert advisory panel last June unanimously urged the FDA to approve the drug. Called Ella in the U.S., the drug already is approved in Europe and sold there as EllaOne.
The only other emergency contraceptive is Plan B. Unlike Ella, which will be available only by prescription, Plan B is sold without a prescription for women aged 17 and older.
Side effects of Ella, similar to those of Plan B, include headache, nausea, abdominal pain, pain/discomfort during menstruation (dysmenorrhea), fatigue, and dizziness. The drug should not be taken by women who are pregnant or nursing.
The two emergency contraceptives work differently:
Ella is manufactured by Paris-based Laboratoire HRA Pharma. It will be distributed by Watson Pharma Inc., of Morristown, N.J.
SOURCES: News release, FDA.
Women's Health Resources
- Your Guide to a Healthy Pregnancy
- What to Know Before You Get Pregnant
- Birth Control and Insurance FAQ
- Symptoms of a Severe Allergic Reaction
- Breast Cancer Treatment Options
- Is Your Body Ready for Pregnancy?